# Application of IV 99mTc-tilmanocept for Imaging of Macrophage-specific Inflammation

> **NCT03523130** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 9 (actual)

## Conditions studied

- HIV

## Interventions

- **DIAGNOSTIC_TEST:** Imaging

## Key facts

- **NCT ID:** NCT03523130
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-03
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-10-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2021-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03523130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03523130, "Application of IV 99mTc-tilmanocept for Imaging of Macrophage-specific Inflammation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03523130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*